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Abstract
Human rhinovirus (HRV) is the predominant cause of upperBackground: 
respiratory tract infections, resulting in a significant public health burden. The
virus circulates as many different types (~160), each generating strong
homologous, but weak heterotypic, immunity. The influence of these features
on transmission patterns of HRV in the community is understudied.
Nasopharyngeal swabs were collected from patients with symptomsMethods: 
of acute respiratory infection (ARI) at nine out-patient facilities across a Health
and Demographic Surveillance System between December 2015 and
November 2016. HRV was diagnosed by real-time RT-PCR, and the VP4/VP2
genomic region of the positive samples sequenced. Phylogenetic analysis was
used to determine the HRV types. Classification models and G-test statistic
were used to investigate HRV type spatial distribution. Demographic
characteristics and clinical features of ARI were also compared.
Of 5,744 NPS samples collected, HRV was detected in 1057 (18.4%),Results: 
of which 817 (77.3%) were successfully sequenced. HRV species A, B and C
were identified in 360 (44.1%), 67 (8.2%) and 390 (47.7%) samples,
respectively. In total, 87 types were determined: 39, 10 and 38 occurred within
species A, B and C, respectively. HRV types presented heterogeneous
temporal patterns of persistence. Spatially, identical types occurred over a wide
distance at similar times, but there was statistically significant evidence for
clustering of types between health facilities in close proximity or linked by major
road networks.
This study records a high prevalence of HRV in out-patientConclusion: 
presentations exhibiting high type diversity. Patterns of occurrence suggest
frequent and independent community invasion of different types. Temporal
differences of persistence between types may reflect variation in type-specific
population immunity. Spatial patterns suggest either rapid spread or multiple
invasions of the same type, but evidence of similar types amongst close health
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 invasions of the same type, but evidence of similar types amongst close health
facilities, or along road systems, indicate type partitioning structured by local
spread.
Keywords
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Introduction
Human rhinovirus (HRV) is the predominant cause of upper 
respiratory tract infections (URTIs) referred to as the 
common cold1–4. The virus has also been associated with lower 
respiratory tract illnesses, including exacerbation of asthma 
and chronic obstructive pulmonary disease5,6. HRV is globally 
ubiquitous and infections usually occur all year-round, although 
peaking in the early autumn and late spring in many temper-
ate or subtropical countries, and in the rainy season in tropical 
countries7–9. Despite most HRV infections being mild, they pose 
a considerable social and economic burden due to time lost 
from work or school, medical attendance and reduced perform-
ance of regular duties10. HRV transmission, infection patterns 
and diversity have been rarely studied in low-income settings 
despite bearing the majority burden of acute respiratory illnesses 
(ARI).
HRVs fall under the genus Enterovirus (HEVs) in the family 
Picornaviridae11. Their genome occurs as a positive-sense, 
single-stranded RNA molecule of approximately 7.2 kb flanked 
by a 5’ untranslated region (UTR) and 3’ poly-A tail. There are 
three HRV species denoted as HRV-A, HRV-B and HRV-C within 
which over 160 genetically distinct types have been identified. 
Identification of these types presently relies on molecular 
typing methods based on sequence analysis of VP1 or VP4/VP2 
proteins encoding regions11,12.
Studies investigating the transmission of HRV show that 
multiple infections frequently occur in individuals over short 
periods of time of the order of a few weeks13–15. In household 
studies, family members experience rapid rates of reinfection 
(for instance, up to 5 infections in adults or 12 infections in 
young children per year) where each infection tends to be 
caused by a different HRV-type and rarely with the same 
HRV-type4,16,17. At a population level of observation, repeated 
reinfections in individuals appears to reflect the introduction 
and circulation of new types in the community, rather than 
persistence of the same HRV types18–21. These observations 
are consistent with evidence from immunological studies on 
HRV that indicate strong homologous type responses and little 
heterotypic immunity to protect individuals against multiple 
types22–24. Moreover, studies have shown that individuals develop 
relatively long-lasting (~ 1 year) type-specific neutralizing anti-
bodies (IgG and IgA) against a specific infecting HRV-type 
but susceptibility to other different HRV types remains and 
infection will occur as so long as there is an exposure25,26.
Hence it might be hypothesized that at the population level 
the virus types spread in a manner independent of each other. 
However, the statistical evidence to support this assertion has 
yet to be undertaken. This would require spatially structured 
study designs to capture temporal-spatial HRV transmission. Data 
of this sort could improve understanding on the nature of spread 
of these viruses at the population level in relation to homotypic 
and heterotypic immunity.
A recently published study27, described the epidemiology of 
respiratory viruses in coastal Kenya through surveillance of 
acute respiratory infection presentations at outpatient facilities 
spatially structured across the well-defined population of the 
Kilifi Health and Demographic Surveillance System (KHDSS)28. 
The present study utilized HRV positive samples from this 
surveillance between December 2015 through November 2016, to 
explore the temporal and spatial circulation patterns and genetic 
diversity of HRV types in the wider Kilifi community.
Methods
Study area
The study was undertaken within Kilifi County in Coastal 
Kenya, at nine health facilities namely: Matsangoni, Ngerenya, 
Mtondia, Sokoke, Mavueni, Jaribuni, Chasimba, Pingilikani and 
Junju, all located within the KHDSS as previously described27. 
The county has a population of about 1,109,735 and is pre-
dominantly rural; the main economic activities include fishing, 
tourism and subsistence farming. The area has a tropical climate 
with two rainy seasons (long rains in April to July and short rains 
in October to December). The KHDSS area in which the study 
was restricted covers 891km2 and has a population of 287,014 
(mid-point 2016) which is heterogeneously distributed with the 
highest density in Kilifi township27.
Study design
Nasopharyngeal swab (NPS) samples and demographic data 
were collected from patients presenting with ARI symptoms at 
the nine selected health facilities within the KHDSS between 
December 2015 and November 2016. The KHDSS area has 21 
public health facilities operating under the Kenya Ministry of 
Health (MOH); the 9 health facilities were purposively selected 
to participate in this study to give a broad representation across 
the geographical region and considering key road networks and 
population densities as described in the previous publication27. 
Recruitment of study participants occurred during the routine 
clinical reviewing procedure by the resident clinician or nurse 
at each health facility. Informed consent was sought from 
participants or their caregiver (if the patient was less than 
18 years of age) and who met the inclusion criteria. Patients 
were eligible for inclusion in the study if presenting with one 
or more of the following symptoms: cough, sneezing, nasal 
congestion, difficulty in breathing, or fast breathing for age 
as defined by World Health Organisation (WHO) guidelines29. 
Individuals were excluded if aged less than 7 days old or if the 
ARI symptoms had been observed for more than 30 days.
A maximum of 15 participants were recruited per facility per 
week. Demographic and clinical history details of the participants 
were collected from eligible patients as described previously27. 
A NPS swab was collected by inserting a sterile nylon flocked 
plastic-shafted swab (503CS01, Copan Diagnostics, Flocked Swab 
Technologies, Italy) into one nostril and twisting 3 times before 
gently removing (taking 5–10 seconds). The NPS sample was 
stored in universal virus transport media and kept at approxi-
mately 8°C in an ice packed cool box. It was then delivered to the 
KEMRI–Wellcome Trust Research Programme laboratories 
approximately 4 hours after collection and stored at −80°C.
Ethical considerations
The study protocol was approved by the KEMRI-Scientific and 
Ethics Review Unit (SERU# 3103) and the University of Warwick 
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Biomedical and Scientific Research Ethics Committee (BSREC# 
REGO-2015-6102). Written informed consent was gathered from 
all patients or their caregiver.
Laboratory procedures
Viral RNA was extracted from each sample using QIAamp Viral 
RNA kit (Qiagen Inc., Valencia, California, USA, Catalog number: 
52906) according to the manufacturer’s instructions. Diagnostic 
PCR was performed to confirm the presence of HRV genetic 
material using real-time RT-PCR with the following primers 
and probes; forward primer (TGGACAGGGTGTGAAGAGC, 
reverse primer (CAAAGTAGTCGGTCCCATCC) and probe (VIC-
TCCTCCGGCCCCTGAATG-TAMRA) (Applied Biosystems, 
United Kingdom, Catalog number 00-45-0818, 00-45-0819 and 
00-45-0820) targeting the 5’ UTR using the following thermocy-
cling conditions; 20 min at 50°C for reverse transcription, 5 min 
for 95° C for polymerase activation and 40 cycles of 15s at 95°C 
and 30s at 60°C as previously described30,31. The PCR runs 
included positive control (of known DNA copies) of the targeted 
5’UTR product generated in-house. Samples were quantified 
based on comparison to the positive control sample. Samples were 
considered positive if ct value <= 35.027. VP4/VP2 coding region 
was amplified for the HRV-positive samples using the following 
primers: forward primer HRV-OF2 (CCGGCCCCTGAATGY-
GGCTAA) and reverse primer HRV-IS2 (TCWGGHARYT-
TCCAMCACCANCC) (Invitrogen, United Kingdom, catalog 
number 00-45-0816 and 00-45-0817) in a RT-PCR reaction using 
Qiagen OneStep RT-PCR kit (Qiagen Valencia, Catalog number: 
210212) as described previously32. Purified PCR products were 
sequenced using Big Dye Terminator 3.1 chemistry (Applied 
Biosystems, Foster City, California, USA, Catalog number 
4337455) using the PCR primers in both forward and reverse 
direction in an ABI Prism 3130xl Genetic Analyzer (Applied 
Biosystems, Foster City, California, USA).
Sequence alignment and phylogenetic analysis
Raw sequence reads were assembled into contigs using 
Sequencher software (version 5, Gene Codes Corporation, 
Ann Arbor, USA). Multiple sequence alignments (MSA) were 
prepared using MAFFT v7.22033. Phylogenetic trees were 
constructed in MEGA v.6.034 with maximum likelihood methods 
under the GTR model and branch support was assessed using 
1000 bootstrap iterations. Types were assigned based on >90% 
nucleotide similarity to rhinovirus prototype sequences (also 
referred to as reference sequences) available in GenBank or phy-
logenetic clustering with reference sequences (with a bootstrap 
support value above 70%).
Statistical analysis
Initial statistical analysis was conducted in STATA version 
13.1 (College Station, Texas). Statistical comparison of demo-
graphic characteristics and clinical features in HRV species 
was conducted using chi square test of association and Fisher’s 
exact test where applicable. Frequency distribution and temporal 
pattern graphs for HRV were generated in R 3.5.1.
Spatial distribution analysis
Analysis centered on investigating spatial heterogeneity of 
HRV detections of HRV types, between health facilities. Our null 
hypothesis was that HRV is introduced and spreads randomly 
within a population, and that HRV types circulate independent of 
each other. Hence we asked: a) Is there evidence that any health 
facility had significantly more HRV detections in the sample of 
NPSs than others? b) Are the frequencies of HRV types found 
per health facility noticeably different from independent random 
mixing? c) Moreover, was the pattern of types detected at each 
facility similar to nearby health facilities compared to further 
away health facilities? To answer these question we used a com-
bination of the classification algorithms provided by the Orange 
data mining toolbox35 and logistic regression implemented by the 
MATLAB v9.4 fitglme function. The null hypothesis of inde-
pendent random HRV type detection was tested using the G-test 
statistic associated with the contingency table of type frequency 
per health facility. Type pattern similarity between health facili-
ties was analysed using multi-dimensional scaling (MDS) imple-
ment in Orange v3.0. MDS represents the similarity between 
high-dimensional data-points optimally on a low dimensional 
(in this case two dimensional) Euclidean metric space, thereby 
revealing patterns and hidden dimensions in the data36. The 
Orange implementation of MDS includes a pairwise similarity 
network linking all points whose high-dimensional similarity 
is close compared to the typical similarity between any two 
data-points; this is a threshold quantity set to the algorithm’s 
maximum therefore including all pairwise connections inferred 
by the Orange MDS algorithm in our analysis.
Nucleotide sequence data set
All newly obtained sequences in this study have been deposited 
into GenBank under accession numbers MH459421-MH460237.
Results
Between December 2015 and November 2016, a total of 
5750 participants were recruited and NPS samples collected 
from 5744 (99.9%) participants as shown in Table 1. Of the 
5744 samples collected, 5741 (99.9%) were tested for HRV. 
HRV was detected in 1057 (18.5%) of the samples tested. 
Of the 1057, 817 (77.8%) were successfully amplified and 
sequenced for the VP4/VP2 genomic region; the remaining 240 
(22.7%) samples either totally failed amplification or had short 
consensus sequences recovered (<300 nucleotides) and were not 
included in phylogenetic analysis.
Among the HRV positive cases, the median age was 2.0 years, 
64.0% were under 5 years of age, and 53.9% were females 
(Table 2). The percentage of samples found to be of species 
A, B and C was 44.1 % ( 360), 8.2% (67) and 47.7% (390), respec-
tively, and did not differ by age or sex (Table 2). Cough (94.5%) 
and nasal discharge (79.9%) were the most common clinical 
presentations. Difficulty in breathing, chest in-drawing, crack-
les, lethargy, nasal flaring, sore throat, wheezing were also 
recorded (Table 2). Clinical presentations differed significantly 
between the typed HRV samples for nasal discharge (p< 0.012) 
and difficult breathing (p< 0.022) (Supplementary Table 1, 
Supplementary File 1).
Phylogenetic analysis revealed 3 major clades representing the 
HRV-A, B and C species (Supplementary Figure 1). Three samples 
were not assigned to any HRV type and these were identified as 
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Table 1. Numbers per month; numbers of participants recruited in the study, 
samples collected from the recruited participants, sample tested and sample 
identified as human rhinovirus (HRV) positive per month.
Month
Total number 
of participants 
recruited
Total number 
of samples 
collected
Total number 
of samples 
tested
Total number of 
sample identified 
as HRV positive
December 153 153 153 11
January 335 333 332 41
February 466 465 465 89
March 457 457 457 72
April 446 445 445 87
May 468 468 467 86
June 557 555 555 66
July 542 542 541 70
August 607 607 607 144
September 579 579 579 164
October 566 566 566 138
November 574 574 574 89
Total 5750 5744 5741 1057 
Table 2. Demographic characteristics of human rhinovirus (HRV) positive and sequenced numbers obtained from 
patient presenting to nine out-patient health facilities in the Kilifi Health and Demographic Surveillance System, 
Coastal Kenya between December 2016 and November 2017.
Total HRV HRV sequenced
n=1057 Total typed 
n=817
HRV-A  
n=360
HRV-B  
n=67
HRV-C 
n=390 p-value
3
 
Demographic 
Characteristics
Age (Years) Mean1 8.3 (14.3) 8.1 (14.3) 9.05(14.91) 8.31(13.50) 7.29 (13.76 )
Median2 2 (0-9) 2 (0-8) 2 (0-13) 2(0-12) 2(0-7)
Sex (%) Female 570 (53.93) 441 ( 53.98) 194 (43.99) 38 (8.62) 209 (47.39) 0.893
Male 487 (46.07) 376 (46.02) 166 (44.15) 29 (7.71) 181 (48.14)
Age Bands (%) <1 317 (29.99) 248 (30.35) 105 (42.34) 24 (9.68) 119 (47.98) 0.192
1–4yrs 359 (33.96) 285 (34.88) 120 (42.11) 19 (6.67) 146 (51.23)
5–9yrs 125 (11.83) 94 (11.51) 38 (40.43) 6 (6.38) 50 (53.19)
10–15yrs 57 (5.39) 38 (4.65) 16 (42.11) 3 (7.89) 19 (50)
>15yrs 199 (18.83) 152 ( 18.6) 81 (53.29) 15 (9.87) 56 (36.84)
Notes 1Mean reported with SD in brackets
2Median reported with IQR in brackets
3chi square test of association/Fisher’s exact test was used test the association between the HRV 
species, sex and age. 
No significant associations between species, sex and age were identified (P < 0.05).
Enterovirus D68 (n=2) and Coxsackievirus B5 (n=1, see offshoot 
in Supplementary Figure 1). A total of 87 different HRV types 
were identified: 39 within species HRV-A, 10 within HRV-B and 
38 within HRV- C. Within HRV-A, A15 was the predominant type 
(n=62), followed by A58 (n=36) and A41 (n=20). Other HRV-A 
types occurred at lower frequencies, ranging from 1 to 19 cases 
(Figure 1 panel A). Within HRV-B, B35 presented as the domi-
nant type (n=41) with the other HRV-B types being detected in 1 
to 8 cases (Figure 1 panel B). Within HRV-C, C22 type was the 
predominant type (n=48), followed closely by C11 (n=45) and 
C38 (n=35). The other HRV-C types were detected as shown in 
Figure 1 panel C.
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Figure 1. A Frequency distribution graph showing the human rhinovirus (HRV)-types detected in patient presenting to the nine health 
facilities within the KHDSS. (a) HRV-A, (b) HRV-B, (c) HRV-C.
HRV circulated throughout the study period as shown in 
Figure 2A. All HRV species were detected in all months except 
in December 2015 when only A and C were detected, although 
fewer samples were collected in this month. HRV incidence peaks 
were observed in August, September and October, while troughs 
were observed in December 2015 and January 2016, which was 
likely due to fewer samples collected in the first two months of 
the study. Despite HRV-C being the most prevalent, there was 
a varying dominance between HRV-A and HRV-C with time 
(Figure 2B). HRV-A appeared dominant in December, January, 
February, May, June, July, October and November while HRV-C 
dominated in the months of March, April, August and September 
(Figure 2C).
Temporal patterns for each of the most frequently occurring 
types (with cases >16 during the year) are displayed in Figure 3. 
Most types displayed a unimodal distribution, with peak 
occurrence including August to October. However, there was 
considerable variation in the spread of the seasonal occurrence 
and modal month.
Regression analysis showed that the month of sample collec-
tion and age of participant were the most informative predictors 
for determining whether an individual tested positive for any 
HRV type. These predictors were identified whether undeter-
mined samples were used in the regression analysis or not. 
Other factors considered were gender and health facility. First, 
five standard classification models (logistic regression, neural 
network using logistic activation functions and one hidden 
layer, k-nearest neighbor classification, tree and random forest 
regression) were compared using random partitions of the data 
into 2/3 training set, 1/3 testing set. Over 100-fold repetitions 
of training and testing each model, both logistic regression 
and the neural network classifiers had 77.2% classification 
accuracy (this increased to 81.0% and 80.9% respectively if 
undetermined samples were removed from the data set). Other 
classification models were less successful and because logistic 
regression is easier to interpret, and likelihood-based, we chose 
to continue our analysis using only logistic regression. Second, 
we removed uninformative predictor variables by comparing 
Akaike information criterion (AIC) for each additive combination 
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Figure 2. Temporal graph showing the distribution and proportions of human rhinovirus (HRV) species over a 12 month period detected in 
patient presenting to 9 health facilities within the Kilifi Health and Demographic Surveillance System (KHDSS) area) a) Frequency of total 
NPS samples collected, total HRV positives and total HRV positives sequenced b) Monthly distribution of HRV species c) Proportion of HRV-
species observed over the 12 months period. HRV-A dominate in the months of December, January, February, May, June, July October and 
November while HRV-C dominated in the months of March, April, August and September.
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Figure 3. Temporal patterns by month of selected human rhinovirus (HRV) types obtained through ARI surveillance at nine health 
facilities in the Kilifi Health and Demographic Surveillance System, Kenya over the period December 2015 to November 2016.
of predictor variables and selecting the logistic regression model 
with lowest AIC. Whether undetermined samples were included 
in the regression analysis or not, in either case the lowest (i.e. 
best) AIC model included only month of sample collection and 
the age of the sample participant as predictors (Supplementary 
Table 2, Supplementary File 1). The most informative models 
implied that the odds ratio of the participants being detected 
HRV positive declined by 0.1-0.2% per month of life, and that 
collection in August to October increased the odds ratio of 
finding HRV positives (Supplementary Table 3, Supplementary 
File 1).
Notably, the health facility of sample collection was not included 
amongst the predictor variables for our classification analysis 
of HRV positive samples. However, this does not exclude the 
possibility of correlations in the types collected between 
different regions. Most sequences typed as belonging to the 
same HRV type were from different regions (represented by 
different health facilities) of the KHDSS and some were 
detected in several months. On the basis of phylogenetic 
analysis, closely related HRV-A15, C11, C22, C28 types were 
present in all 9 regions of KHDSS, and A66, B35, C14 and C44 
types detected in 8 different regions. In other cases, identical 
HRV- types were shared in the different geographical regions 
ranging from 1 to 7 geographical regions. Nonetheless, the 
contingency table of type collected at each health facility 
(Supplementary Table 4, Supplementary File 1) reveals highly 
significant evidence to reject independence of type occur-
rence at each health facility (G statistic = 849.7, dof = 704, 
P = 1.25×10-4) in favour of clustering of type occurrence by 
health facility.
In addition to clustering of individual type occurrence at the 
health facilities we also found evidence of greater similarity 
in HRV type distribution between the health facilities located 
near the road network in central Kilifi area (Chasimba, Jaribuni, 
Mavueni, Mtondia, Ngerenya, Sokoke) compared to the health 
facilities off the main road in the south of the KHDSS area 
(Junju, Pingilikani) and further north up the main highway 
(Matsangoni) (Figure 4A). We measured the pairwise similarity 
of the type distribution at each health facility as the total abso-
lute differences in their type occurrences shifted by the data 
median and rescaled by the median absolute distance from median 
(i.e. the rescaled Manhattan metric recommended for high 
dimensional data sets37). We used the Orange implementation 
of MDS (see methods) to optimally represent the type distri-
bution similarities on a plane along with a similarity network 
(Figure 4B). The similarity network distinguishes between 
the type distributions of health facilities in the central part of 
Kilifi area on the road network, in particular the central similar-
ity clique (Mtondia, Ngerenya, Sokoke), and the type distribu-
tion observed on the outskirts and harder to travel to parts of the 
Kilifi area. The MDS representation condenses and quantifies 
the information derived by direct visual comparison of the type 
distributions (Figure 4C).
Discussion
This study investigated the HRV infection, diversity and type 
distribution in individuals presenting with ARI symptoms for 
outpatient care at nine spatially structured health facilities in 
rural coastal Kenya over 12 months period. All three HRV 
species co-circulated with HRV-A and HRV-C co-predominant. 
This observation agrees with a previous study conducted in 
rural coastal Kenya38. Remarkably, a total of 87 HRV types were 
identified in circulation over the twelve months, representing 
52.7% of all known HRV types. This observation could be 
attributed to the natural ability of each type to independently 
cause an infection with limited cross-immunity with other 
Page 8 of 16
Wellcome Open Research 2018, 3:128 Last updated: 12 NOV 2018
Figure 4. Type distribution similarity between health facilities in Kilifi Health and Demographic Surveillance System (KHDSS). A: Road 
map of KHDSS showing main highway (purple line), local roads (brown lines) and health facilities (red dots). B: Multidimensional scaling of 
the type distribution at each health facility along with pairwise similarity matrix. C: The type distribution at each health facility represented as 
a mosaic plot. The colors follow types in species human rhinovirus (HRV)-A (red, orange, yellow, green), HRV-B (light blue), and HRV-C (blue, 
dark blue, purple, red). Band widths are proportional to the number of each type sampled at the health facility.
types39. Therefore, as long as there are new introductions and 
exposure to new HRV-types, the population experiences a series of 
new HRV infections throughout the year18–20.
As expected, there was a decrease in the detection of HRV 
cases with an increase in the age of the patients. The major-
ity of the HRV positive patients were children below the age of 
5 years (63.95%) and a statistically significant decrease in HRV 
positives amongst older ages was observed. The consistent 
finding of high proportions of HRV infections in children 
below the age of 5 years reiterates the need to focus control 
strategies to this age group since they are the most vulnerable, 
and presumably make the greatest contribution to community 
transmission. The low rates of detection of HRV types in adults 
may reflect the gradual development of type-specific immunity 
due to increased exposure throughout life.
We identified two Enterovirus D68s and one Coxsackievirus 
B5 in the nasopharyngeal samples initially classified as HRV 
positive using a real-time RT-PCR method. This is not unusual as 
the real time RT-PCR target region is genetically close between 
HRV and other members of the genus Enterovirus32. A previous 
study conducted in Kilifi using the same molecular diagnostic 
assay reported a similar detection of non-HRV enteroviruses38. 
Further, a recent study in Tanzania observed a relatively high 
prevalence of non-HRV enteroviruses in NPS sample including 
poliovirus type 1, enterovirus-D68, A71, echovirus-6, 7, 9 , 11 and 
a variety of coxsackievirus serotypes40.
Phylogenetic analysis revealed close genetic association between 
sequences from different health facilities, with high intra-type 
genetic identities between the sequences from different health 
facilities (87 -100%). In some cases the identical HRV-types 
were circulating simultaneously in different geographical regions 
separated by a distance as far as 30 km apart. Supported by the 
low genetic variation in the VP4/VP2 coding sequences and the 
concurrent distribution between these identical HRV-types it 
is probable that there is a rapid spread of HRV-types within the 
KHDSS once introduced and or many introductions of the same 
type into different areas of the KHDSS.
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Despite phylogenetic evidence for rapid spread across the 
KDHSS, there is highly significant evidence for variation in the 
distribution of HRV-types between health facilities. An obvious 
mechanism that accounts for the variation in HRV-type 
distribution between health facilities is that transmission occurs 
more frequently between people attending the same health 
facility compared to those who attend other health facilities. In 
this case, sharing a health facility is a proxy for being more likely 
to live nearby and share the same social amenities and gather-
ings which are hotspot for transmission of respiratory viruses. 
Additionally, multidimensional scaling of the type distributions 
reveals greater type distribution similarity between the health 
facilities servicing parts of central Kilifi area that are more 
easily travelled between by road compared to the health facili-
ties located significantly off the highway, or much further north 
along the highway. Spatial differentiation of type distribution, 
along with greater similarity in type distribution between the 
areas where we expect more human co-transit, is consistent with 
the expectations of spatial metapopulation models of infectious 
disease transmission41,42. However, it is comparatively rare to 
be able to demonstrate direct evidence of metapopulation 
effects in transmission, as we have done (see the discussion in 
Grenfell et al.43).
Observed occurrence of multiple typical mini-epidemics 
caused by specific types in the community is possibly due to 
homotypic immunity caused by HRV types, if the commu-
nity population had stronger herd heterotypic immunity against 
various types we would expect minimum number of HRV cases, 
moreover we would expect the virus to remain in the commu-
nity for shorter time periods (few months). Therefore, due to the 
homotypic immunity in HRV, the population will continue to 
report HRV incidence as other new HRV types are introduced 
into the community. Also, the differences in circulation periods 
observed among HRV-types could be as a result of stochastic 
differences in frequency of introduction and onward transmis-
sion of the HRV types, and also differences in the community 
level immunity to the different types given their differences 
in incidence in the recent past. In some cases type-specific 
epidemics were served with different variants of the same 
HRV type probably as a result of separate introductions into the 
community at different times over the year. Moreover, compar-
ing the HRV incidence with other respiratory viruses, as shown 
in the preceding study27, HRV tend to peak in the second half of 
the year as other respiratory viruses report low incidence during 
this period. An explanation for this observation could be a case 
of virus interaction that whatever triggers (either environment 
or biological) high incidence in HRV in the 3rd quarter of the 
year, causes low incidence in the other viruses. Further studies 
are needed to evaluate whether virus interaction affects incidence 
and transmission of individual viruses in the population.
Although the study has strength in its structured design and its 
implementation, it faced a number of limitations. First, there was 
low patient recruitment in the initial study months (December 
2015 and January 2016) due to clinic closure on public holidays 
or people migrating to other areas of the country during festive 
season. This may have contributed to the lower observed HRV 
prevalence compared to the other months of study. Second, we 
failed to sequence the VP4/VP2 coding region for 22.2% of 
HRV positives samples, possibly due to low virus titers in 
the nasopharyngeal samples inferred from high Ct values 
(Ct value>33) in these samples. Third, since a maximum 
sample number per clinic was fixed, changes in prevalence of 
one virus, for example during a seasonal peak of coronavirus, 
would lead to fewer samples testing positive for other viruses. 
Hence there would be lack of independence of numbers of each 
virus type, or even between HRV types, over time, affecting 
temporal patterns of absolute numbers. However, the preva-
lence of each virus or virus type at any timepoint will reflect 
that circulating in the community.
In summary, we observed co-circulation of the three HRV 
species in all nine health facilities scattered in the KHDSS area 
of coastal Kenya, and combined we documented the circulation 
of a majority of all known HRV types to date (87/165) within a 
single year period in this small geographical area. Some of the 
HRV–types circulated in the KHDSS population close to all 
months of observation (10/12) suggesting marked local per-
sistence of some types while others appeared and faded from 
circulation quite rapidly possibly due to low herd homolo-
gous immunity for the former and stronger herd homologous 
immunity in the latter. HRV Transmission in the community 
is enhanced in people living close to one another and between 
areas linked by road network. Our study reports a substantial 
HRV burden among patients seeking outpatient care in this 
low-income setting of tropical Africa and a differential preva-
lence of the HRV species and types with significant differences 
in their local spatial-temporal distribution.
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Supplementary material
Supplementary Figure 1: Phylogenetic analysis of 817 human rhinovirus (HRV) sequences from the Kilifi Health and Demo-
graphic Surveillance System (KHDSS) including 1 Coxsackievirus and 2 Enterovirus D68 sequences diagnosed as HRV by PCR. 
Different species are indicated by different tree branch color; black, HRV species A; red, HRV- species C; blue, HRV species B; 
pink, EV-D68; green, CV species B. HRV human rhinovirus, EV enterovirus, CV coxsackievirus.
Click here to access the data.
Supplementary File 1: document containing the following Supplementary Tables: Click here to access the data 
Supplementary Table 1: Statistical comparison of clinical features and human rhinovirus (HRV) species.
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The authors have determined human rhinovirus spatial-temporal epidemiology in rural coastal Kenya,
observed through outpatient surveillance. This study was conducted over 11 months and showed a high
prevalence and diversity of HRV in out-patient with symptoms of acute respiratory infection.
Globally, the paper is very interesting because it allows not only to know the different serotypes of
rhinovirus circulating in Kenya but also their spatial-temporal circulation. The study is also a contribution
to the scarcity of data observed in low-income settings regarding HRV circulation and diversity.
Some remarks and comments about the study are noted:
: The case definition used should be more specific and explain why children under 7 areStudy design
excluded from the study. A more appropriate reference for acute respiratory infections should be used
(WHO Guideline describing standards for influenza surveillance including case definitions for ILI and
SARI ).
 
Authors should specify if the sample is a nasopharyngeal or nasal specimen swab. The cited technique
appears to be a nasal swab and not a nasopharyngeal swab.
Laboratory procedures
Why are samples with Ct> 35 considered negative? This was not explained in reference 27, which the
author refers to us.
The multiplex real-time PCR assay system used for the detection of  rhinoviruses does not differentiate
between rhinoviruses and enteroviruses. Other enteroviruses such as Cox B5 and EV-D68 have been
found, and this may lead to overestimation of the prevalence of rhinoviruses
 
Discussion
Remarkably, a total of 87 HRV types were identified in circulation over the twelve months, representing
52.7% of all known HRV types: Could the authors provide the total number of HRV types to better
understand how the 52.7% were obtained
 
Other members of the genus  was identified: the authors could discuss the use of moreEnterovirus 
specific detection methods for rhinovirus than to mention similar studies. This part must be more
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 discussed.
 
The authors mention a predominance of rhinovirus C followed by rhinovirus A: authors can discuss this
predominance by analyzing the clinical signs of the study population. It is known that rhino C is more
prevalent in asthmatics.
 
When discussing occurrence of multiple typical mini-epidemics caused by specific types in the
community, the authors should refer to other studies made elsewhere and add these references to the
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The study is a nice examination of the complexity and scope of RV circulation. It adds to an established
but growing literature acknowledging that “rhinovirus” is not one virus, but a large group of distinct viruses
capable of apparently independent co-circulation. This circulation includes the majority of genotypes
(types) at a single location over time using molecular methods augmented with sequencing. The paper
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capable of apparently independent co-circulation. This circulation includes the majority of genotypes
(types) at a single location over time using molecular methods augmented with sequencing. The paper
notes some important aspects for further study.
Some questions and comments about the study include:
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tropical climate. ollow-up on these and putting the study findings into context in the discussion
would be helpful
Could the authors add some information about why they excluded infants younger than days and
people with ARI symptoms for longer than 30 days?
The authors note that their genotyping process is “as previously described”. But it is quite different
including not being nested RT-PCR (which can enhance sensitivity). Could they provide more
detail – perhaps consider adding their method in complete detail to   andhttps://www.protocols.io/
referencing to that in this paper.
Could the authors better justify their choice to use a 35 Ct threshold for PCR Also–please check
that the reference used is correct.
Did the evidence 300nt was detrimental to calling genotypes? For example, they use truncated
longer amplicons and the outcome by BLAST to determine a real difference?
The authors might consider the term “species ” to describe the “varying dominance” between HRV
species discussed around Figure 2.
Could the authors add a comment about circulation of RVs throughout the year and the role this
might play, if it occurs, in ‘’ of the same or different RV
Could the add some referenced to pre-existing knowledge where discussion comments have
about (a) of heterotypic immunity to RVs and (b) virus interactions?
In their summary, the authors imply that the patterns in genotypes and species exchange detected
in the nine health facilities are the same as those in the community. How sure can they be that
there is not a mild and asymptomatic non-presenting infections?
Could the authors expand on their 22.2% VP4/VP2 sequencing failure in the context of the
comment about changed methods above?
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